Panoramic Investment Advisors, LLC Celldex Therapeutics, Inc. Transaction History
Panoramic Investment Advisors, LLC
- $136 Billion
- Q1 2024
A detailed history of Panoramic Investment Advisors, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Panoramic Investment Advisors, LLC holds 6,500 shares of CLDX stock, worth $199,225. This represents 0.2% of its overall portfolio holdings.
Number of Shares
6,500
Previous 6,500
-0.0%
Holding current value
$199,225
Previous $258 Million
5.82%
% of portfolio
0.2%
Previous 0.22%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
195Shares Held
63.5MCall Options Held
206KPut Options Held
176K-
Wellington Management Group LLP Boston, MA8.08MShares$248 Million0.05% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$144 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.74MShares$115 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ3.39MShares$104 Million9.76% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.33MShares$102 Million2.17% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.43B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...